Claes-Göran Löfdahl
41 – 50 of 147
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2008
-
Mark
COPD and co-morbidities, with special emphasis on cardiovascular conditions
(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
-
Mark
A real-life cost-effectiveness evaluation of budesonide/formoterol maintenance and reliever therapy in asthma
(
- Contribution to journal › Article
-
Mark
Hospital admission rates among men and women with symptoms of chronic bronchitis and airflow limitation corresponding to the GOLD stages of chronic obstructive pulmonary disease - A population-based study
(
- Contribution to journal › Article
-
Mark
Symbicort SMART - Effective treatment at a lower cost
(
- Contribution to journal › Published meeting abstract
-
Mark
Increased Prevalence of Multiple Sclerosis Among COPD Patients and Their First-Degree Relatives: A Population-based Study.
(
- Contribution to journal › Article
-
Mark
Specific nasal symptoms and symptom-provoking factors may predict increased risk of developing COPD.
(
- Contribution to journal › Article
- 2007
-
Mark
Protein Expression Patterns Associated with Progression of Chronic Obstructive Pulmonary Disease in Bronchoalveolar Lavage of Smokers.
(
- Contribution to journal › Article
-
Mark
Mortality risks among heavy-smokers with special reference to women: a long-term follow-up of an urban population
(
- Contribution to journal › Article
-
Mark
Possible protection by inhaled budesonide against ischaemic cardiac events in mild COPD.
(
- Contribution to journal › Article
-
Mark
Zileuton added to low-dose inhaled beclomethasone for the treatment of moderate to severe persistent asthma
(
- Contribution to journal › Article